CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and challenges that biopharma CEOs and presidents can relate to and should be aware of. To submit a CEO Corner article, please follow these guidelines.
Benefits Of Beantown Biotech And Lessons For Life Science Leaders
I have had the opportunity to experience and contribute to the thriving life sciences industry in Massachusetts, and I can say that it has all of the components needed to ultimately bring new treatments forward for patients.
The Role Of Failure In Innovation
Being an innovator is not for the faint of heart. Failure is a natural part of the innovation process, and you need to be comfortable with it and embrace it.
Key Learnings While Forging A Partnership In Unprecedented Times
My 25+ years in this industry have provided me with unique insights into partnership development strategy and how to leverage this knowledge even amidst a global pandemic.
Hiring C-Suite Leadership During The Pandemic
We have continued to recruit senior leadership and board members during these difficult times, and we are seeing new interviewing and hiring practices evolve. Here are a few of our lessons we’ve learned.
How The Right Culture Leads To Highly Productive Teams
“Culture” has gone from being a buzzword to a commonplace term in the last several years, and if a company isn’t careful, it can become almost meaningless as it's tossed around in documents and HR discussions.
Moving From Crisis To Lasting Change
Our industry has an opportunity — an obligation really — to harness and improve upon the efforts made over the last few months to formalize a new operating model utilizing all of the clinical, digital, and pharmacological tools at our disposal to raise the standard of care for people well into the future.
Building A Biotech: The Third Key Ingredient Beyond Innovation & Funding
I would argue that if biotech organizations, at the R&D stage in particular, cannot successfully manage their communications practices, they are much more likely to fail regardless of the merits of their innovative technology or ability to secure funding.
5 Considerations When Moving From Big Pharma To Biotech
Before making my decision, I needed to evaluate whether I was ready to face the unique challenges posed by biotech life. That’s why I thought it prudent to screen potential opportunities using a five-part framework.
Leading And Managing Change During A Time Of Transition And Cultural Transformation
While strategic leadership during times of transition and transformation can be especially challenging, consistently prioritizing organizational goals and strategies is paramount to success.
Leading With Authenticity In Turbulent Times
Today, as we strive to be adaptive and productive during the pandemic, leaders can play an important role in “normalizing” the unthinkable and leading with authenticity and truth has never been more important.
BEYOND THE PRINTED PAGE
We Need To Expand How We Value Companies
During an interview for an upcoming feature in Life Science Leader, Sanjeev Redkar, Ph.D., cofounder and president of Apollomics (a biopharmaceutical company discovering and developing oncology treatments), discussed the topic of an exit strategy.
Have You Heard Of The Chinese Biopharmaceutical Association (CBA)?
While working at his first job at Human Genome Sciences in 1995, Guo-Liang Yu, Ph.D., decided to create The Chinese Biopharmaceutical Association (CBA), one of the largest Chinese American professional associations in the U.S.
What 4 Biopharma CFOs Think About The Future Of Remote Work
While we touch on remote work in Life Science Leader’s annual outlook issue, the responses in this article from four biopharmaceutical CFOs to questions on the subject shed additional light on the challenge that lies ahead for employers.
LIFE SCIENCE LEADER BLOGS
Let’s Talk About JPM 2021
Rob Wright, chief editor of Life Science Leader, shares thoughts on attending the 39th Annual J.P. Morgan Healthcare Conference (JPM) which was 100% virtual this year.
What Went Right In 2020? My Top 5 List
Life Science Leader's Rob Wright reviews five things that went right in 2020.